Invariant when
conventional systems fail.
Aeterion is a London biotechnology research company developing new ways to access the molecular history of living systems, to make biology more observable, measurable and interpretable.
Research for a broader ecosystem
Knowledge
for what comes next.
What drives us
Biology is measured in snapshots. A snapshot tells you what a system is, not how it came to be — and much of what would explain it is not captured at all. Aeterion's research is directed at that gap, and at what a fuller picture of biology could mean for research and for real-world application.
Not just what biology is, but what it has been.
New ways to see and measure the inner life of cells and systems.
Capturing change over time to reveal richer biological context.
Turning complex molecular data into meaningful insight.
Our approach
Our approach brings together advances in molecular measurement, computational analysis and systems thinking to resolve how molecular state changes over time.
A more complete view of life.
Building the tools to explore biology's temporal dimension and what it can tell us.
Built for lasting impact
Grounded in rigorous science and a commitment to quality.
Built to work alongside academic, clinical and industry partners.
Focused on knowledge that endures, for a more informed future.
Company
Aeterion is founded on a single premise: that breakthrough innovations should remain invariant when conventional systems fail.
Aeterion is an early-stage biotechnology research and development company. Its work is proprietary and foundational: making the molecular history held within living systems measurable and useful. The company does not yet report programmes, data or partnerships.
Aeterion was founded by Catherine Spencer.